Max Healthcare Institute Limited (BOM:543220)
India · Delayed Price · Currency is INR 1,098.55
-27.95 (-2.48%)
At close: Jul 31, 2026
Max Healthcare Institute Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 83,735 | 70,285 | 54,060 | 45,626 | 39,366 |
| 83,735 | 70,285 | 54,060 | 45,626 | 39,366 | |
Revenue Growth | 19.14% | 30.01% | 18.49% | 15.90% | 56.96% |
Cost of Revenue | 31,471 | 26,511 | 20,529 | 17,314 | 17,481 |
Gross Profit | 52,263 | 43,774 | 33,531 | 28,312 | 21,885 |
Selling, General & Admin | 17,940 | 14,747 | 11,169 | 9,863 | 8,729 |
Other Operating Expenses | 11,868 | 10,157 | 7,159 | 5,887 | 3,365 |
Operating Expenses | 34,274 | 28,499 | 20,778 | 18,072 | 14,305 |
Operating Income | 17,990 | 15,275 | 12,753 | 10,240 | 7,580 |
Interest Expense | -2,150 | -1,488 | -445.6 | -713.2 | -900.1 |
Interest & Investment Income | 1,150 | 1,172 | 1,562 | 1,124 | 750.9 |
Currency Exchange Gain (Loss) | -26.6 | -7 | 3 | -2.4 | -3.4 |
Other Non Operating Income (Expenses) | 213.5 | 204.4 | 41.6 | 86.7 | 207.3 |
EBT Excluding Unusual Items | 17,177 | 15,158 | 13,914 | 10,735 | 7,634 |
Merger & Restructuring Charges | -143.4 | -736.3 | - | - | -90.3 |
Gain (Loss) on Sale of Assets | 6.5 | 1.1 | 4.5 | 13.3 | -30.6 |
Asset Writedown | - | - | - | - | -0.6 |
Other Unusual Items | -283.8 | -358.8 | -265.4 | -111.2 | -123.8 |
Pretax Income | 16,756 | 14,064 | 13,653 | 10,637 | 7,389 |
Income Tax Expense | 2,332 | 3,305 | 3,077 | -397.9 | 1,339 |
Earnings From Continuing Operations | 14,424 | 10,759 | 10,576 | 11,035 | 6,051 |
Net Income to Company | 14,424 | 10,759 | 10,576 | 11,035 | 6,051 |
Net Income | 14,424 | 10,759 | 10,576 | 11,035 | 6,051 |
Net Income to Common | 14,424 | 10,759 | 10,576 | 11,035 | 6,051 |
Net Income Growth | 34.07% | 1.73% | -4.16% | 82.38% | - |
Shares Outstanding (Basic) | 972 | 972 | 972 | 970 | 967 |
Shares Outstanding (Diluted) | 977 | 977 | 975 | 972 | 969 |
Shares Change | -0.00% | 0.20% | 0.39% | 0.24% | 12.30% |
EPS (Basic) | 14.83 | 11.07 | 10.89 | 11.38 | 6.25 |
EPS (Diluted) | 14.76 | 11.01 | 10.84 | 11.36 | 6.24 |
EPS Growth | 34.06% | 1.57% | -4.58% | 82.05% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,488 | 4,935 | 3,357 | 9,485 | 1,872 |
Free Cash Flow Per Share | 1.52 | 5.05 | 3.44 | 9.76 | 1.93 |
Dividend Per Share | 2.000 | 1.500 | 1.500 | 1.000 | - |
Dividend Growth | 33.33% | 0% | 50.00% | - | - |
Gross Margin | 62.41% | 62.28% | 62.02% | 62.05% | 55.59% |
Operating Margin | 21.48% | 21.73% | 23.59% | 22.44% | 19.25% |
Profit Margin | 17.23% | 15.31% | 19.56% | 24.19% | 15.37% |
Free Cash Flow Margin | 1.78% | 7.02% | 6.21% | 20.79% | 4.75% |
EBITDA | 21,788 | 18,312 | 14,819 | 12,226 | 9,465 |
EBITDA Margin | 26.02% | 26.05% | 27.41% | 26.80% | 24.04% |
D&A For EBITDA | 3,798 | 3,037 | 2,066 | 1,986 | 1,886 |
EBIT | 17,990 | 15,275 | 12,753 | 10,240 | 7,580 |
EBIT Margin | 21.48% | 21.73% | 23.59% | 22.44% | 19.25% |
Effective Tax Rate | 13.92% | 23.50% | 22.54% | - | 18.12% |
Revenue as Reported | 85,361 | 71,841 | 55,830 | 47,018 | 40,588 |
Advertising Expenses | - | - | - | - | 446.2 |